Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Lifco on bond issue (1)
Mandate

Vinge advised Lifco on bond issue

December 07, 2017

Lifco AB (publ) has issued two unsecured bond loans of in total SEK 1,000 million, with a tenor of two years.


The bonds were listed on Nasdaq Stockholm on 6 December 2017.

Vinge acted as legal advisor to Lifco. The Vinge team primarily consisted of Christian Lindhé and Carl Öberg, together with Erik Sjöman, Henrik Ossborn and Fredrik Christiansson.

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026